GET THE APP

Biotechnology and peopleandprime;s health: The infectious disease | 40755
Journal of Proteomics & Bioinformatics

Journal of Proteomics & Bioinformatics
Open Access

ISSN: 0974-276X

+44 1223 790975

Biotechnology and people′s health: The infectious diseases and phytonutraceuticals factor


Joint Event on 9th World Biomarkers Congress & 20th International Conference on Pharmaceutical Biotechnology

December 07-09, 2017 | Madrid, Spain

Abayomi Oguntunde, Victor O Fadipe, Fashina Sanya and Ibrahim H Doko

Federal Ministry of Science and Technology, Nigeria
University of Zululand, South Africa
Raw Materials Research and Development Council, Nigeria

Posters & Accepted Abstracts: J Proteomics Bioinform

Abstract :

Phytonutraceuticals generally promises to have greater impacts on health delivery and its management ranging from drug discovery and disease diagnosis. Phytonutraceuticals in both developed and developing countries are alive with rare species that possess pharmacologically active constituents for possible cure of many chronic diseases such as cancer, Tuberculosis, HIV/ AIDs, sickle cell anaemia, neurological disorders, and many metabolic diseases. Phytonutraceuticals is a mixture of compounds such as carotenoids, flavonoids and Isoflavonoids (Polyphenols), Phytates (Inositol phosphates), Lignans, Isothiocynates and Indoles, Phenols, Sulphides and Thiols, Terpenes and thus serves as antioxidants, enhance immune response, enhance cell-cell communication, alter estogen metabolism, repair DNA damage caused by smoking and other toxin exposures, others. The Phytonutraceuticals revolution began in the 1980s as a result of substantial evidence to support increase in life expectancy after its administration directly or as foods. The high cost of orthodox medicine pave way for the emergency of Phytonutraceuticals in countries like US, EU and JAPAN. Most African countries rural dwellers depend on Phytonutraceuticals. Literature have it that, most of these plants from savannah and tropical rainforest bio accumulates such Phytonutraceuticals in minute��?s quantities that are not enough to characterise it and biotechnology is right now the rapidly advancing frontier of science. It has illuminated more deeply and more extensively many genetic, chemical, physiological, and mathematical processes which can be used to mass produce biologically active Phytonutraceuticals in plants. The main objective of the study is to bring to fore the advance in evolution of biotechnology techniques as it affects Phytonutraceuticals development. This will further strengthen research collaboration involving botanist, biotechnologist and chemist etc to further strengthening better health care management.

Top